Gsa Capital Partners LLP Tff Pharmaceuticals, Inc. Call Options Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0
View Full List

About TFF Pharmaceuticals, Inc.

TFFP Quotes by TradingView
  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.92M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email